AzTrials
AzTrials

StrokeNCT05395637

Reliability of Longshi Scale With Remote Assessment

An observational study of Stroke and Telemedicine, run by Shenzhen Second People's Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To explore the reliability of remote Longshi Scale assessment with smartphone video calls by comparing the consistency of remote assessment and bedside assessment, as well as the test-retest reliability of the remote assessment. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Telemedicine
How many people
129 participants
Where
1 siteChina
Study dates
20 May 2022to 30 May 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Stroke survivors from the Department of Rehabilitation Medicine at Shenzhen Second People's Hospital are invited to participate in this study according to the inclusion and exclusion criteria

Who may be able to join

  • a.Stroke survivors
  • aged 18 and above;
  • diagnosed with cerebral infraction or intracerebral hemorrhage;
  • stroke onset2 weeks;
  • stable vital signs (heart rate, blood pressure, respiratory rate, oxygen saturation and temperature);
  • voluntary or guardian consent to participate in the study.
Show all 10Show fewer
  • b.Evaluators
  • <!-- -->
  • registered rehabilitation practitioner;
  • experience in rehabilitation scientific research or education related work for more than two years

Who cannot join

  • a.Stroke survivors
  • brain tumor, Parkinson's disease or active epilepsy within past three months;
  • a history of mental illness such as mania or delirium;
  • participation in any other clinical study. b.Evaluators
  • <!-- -->
  • unable to finish the training of Longshi Scale or use smartphones proficiently.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Shenzhen Second People's Hospital

    Shenzhen, Guangdong

Other trials in China

About this study

Official title: Reliability of Longshi Scale With Remote Assessment of Smartphone Video Calls for Stroke Patients'Activities of Daily Living

To explore the reliability of remote Longshi Scale assessment with smartphone video calls by comparing the consistency of remote assessment and bedside assessment, as well as the test-retest reliability of the remote assessment. The evaluation duration of these two methods was recorded and the level of satisfaction of patients and evaluators was investigated.

Conditions
Stroke, Telemedicine
Keywords
Stroke, Tele-rehabilitation, Activities of Daily Living
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05395637
Study groupRoleWhat they receive
Assessed with the remote assessment of Longshi Scale first and then with bedside assessmentNot described
Assessed with the bedside assessment of Longshi Scale first and then with remote assessmentNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Consistency of the disability degree evaluated using the remote assessment and the bedside assessment of Longshi Scale.

    Weighted kappa(wK) and Bland-Altman were used to determined the consistency between the results of remote assessment method and bedside assessment method. The interpretation of wK scores was in accordance with published standards (values>0.75 indicating excellent agreement beyond chance; 0.4~0.75, moderate agreement beyond chance; <0.4, poor agreement beyond chance).

    Measured: Within 24 hours

Secondary outcomes (3)
  1. The test-retest reliability of the remote video assessment

    the result of remote assessment test-retest was analyzed by Weighted kappa(wK) scores.The interpretation of wK scores was in accordance with published standards (values>0.75 indicating excellent agreement beyond chance; 0.4~0.75, moderate agreement beyond chance; <0.4, poor agreement beyond chance).

    Measured: Within 24 hours after first evaluation

  2. Satisfaction survey of remote assessment

    The satisfaction survey data were summarized as mean±standard deviation, and also summarized as the percentage of satisfaction categories.

    Measured: Within 24 hours after the remote assessment

  3. Assessment duration

    The assessment duration was analyzed by independent t-test.

    Measured: Within 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 May 2022
  2. Study start20 May 2022 (estimated)
  3. Primary completion25 May 2022 (estimated)
  4. Study completion30 May 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
129 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05395637
Sponsor's protocol ID
20220224002
Status last verified
May 2022
First submitted
25 May 2022
Last updated
27 May 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Telemedicine, run by Shenzhen Second People's Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Consistency of the disability degree evaluated using the remote assessment and the bedside assessment of Longshi Scale. (time frame: Within 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in